229 related articles for article (PubMed ID: 32487995)
1. Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy.
Li M; Parker BL; Pearson E; Hunter B; Cao J; Koay YC; Guneratne O; James DE; Yang J; Lal S; O'Sullivan JF
Nat Commun; 2020 Jun; 11(1):2843. PubMed ID: 32487995
[TBL] [Abstract][Full Text] [Related]
2. Impact of left ventricular assist device therapy on the cardiac proteome and metabolome composition in ischemic cardiomyopathy.
Shahinian JH; Rog-Zielinska EA; Schlimpert M; Mayer B; Tholen S; Kammerer B; Biniossek ML; Beyersdorf F; Schilling O; Siepe M
Artif Organs; 2020 Mar; 44(3):257-267. PubMed ID: 31494943
[TBL] [Abstract][Full Text] [Related]
3. Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy.
Lionetti V; Matteucci M; Ribezzo M; Di Silvestre D; Brambilla F; Agostini S; Mauri P; Padeletti L; Pingitore A; Delsedime L; Rinaldi M; Recchia FA; Pucci A
J Cell Mol Med; 2014 Mar; 18(3):396-414. PubMed ID: 24444256
[TBL] [Abstract][Full Text] [Related]
4. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
[TBL] [Abstract][Full Text] [Related]
5. Regional heterogeneity of decreased myocardial norepinephrine and increased lipid peroxidation levels in patients with end-stage failing heart secondary to dilated or ischemic cardiomyopathy.
Rochette L; Tatou E; Vergely C; Maupoil V; Bouchot O; Mossiat C; Jazayeri S; Benkhadra S; Brenot R; Girard C; David M
J Heart Lung Transplant; 2008 Jul; 27(7):767-74. PubMed ID: 18582807
[TBL] [Abstract][Full Text] [Related]
6. Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.
Roselló-Lletí E; Alonso J; Cortés R; Almenar L; Martínez-Dolz L; Sánchez-Lázaro I; Lago F; Azorín I; Juanatey JR; Portolés M; Rivera M
J Cell Mol Med; 2012 Oct; 16(10):2471-86. PubMed ID: 22435364
[TBL] [Abstract][Full Text] [Related]
7. Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy.
Lee S; Lu R; Müller-Ehmsen J; Schwinger RH; Brixius K
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1134-8. PubMed ID: 20804510
[TBL] [Abstract][Full Text] [Related]
8. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
[TBL] [Abstract][Full Text] [Related]
9. Characterization of inwardly rectifying K+ channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy.
Koumi S; Backer CL; Arentzen CE
Circulation; 1995 Jul; 92(2):164-74. PubMed ID: 7600647
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix proteins and matrix metalloproteinases differ between various right and left ventricular sites in end-stage cardiomyopathies.
Herpel E; Singer S; Flechtenmacher C; Pritsch M; Sack FU; Hagl S; Katus HA; Haass M; Otto HF; Schnabel PA
Virchows Arch; 2005 Apr; 446(4):369-78. PubMed ID: 15806380
[TBL] [Abstract][Full Text] [Related]
11. RNA sequencing analysis and atrial natriuretic peptide production in patients with dilated and ischemic cardiomyopathy.
Tarazón E; Roselló-Lletí E; Rivera M; Ortega A; Molina-Navarro MM; Triviño JC; Lago F; González-Juanatey JR; Orosa P; Montero JA; Salvador A; Portolés M
PLoS One; 2014; 9(3):e90157. PubMed ID: 24599027
[TBL] [Abstract][Full Text] [Related]
12. In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy.
Liu S; Xia Y; Liu X; Wang Y; Chen Z; Xie J; Qian J; Shen H; Yang P
Oncotarget; 2017 Jul; 8(29):48321-48332. PubMed ID: 28427148
[TBL] [Abstract][Full Text] [Related]
13. Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy.
Brodde OE; Vogelsang M; Broede A; Michel-Reher M; Beisenbusch-Schäfer E; Hakim K; Zerkowski HR
J Cardiovasc Pharmacol; 1998 Apr; 31(4):585-94. PubMed ID: 9554809
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure.
Böhm M; Eschenhagen T; Gierschik P; Larisch K; Lensche H; Mende U; Schmitz W; Schnabel P; Scholz H; Steinfath M
J Mol Cell Cardiol; 1994 Feb; 26(2):133-49. PubMed ID: 8006975
[TBL] [Abstract][Full Text] [Related]
16. Heart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathy.
Roselló-Lletí E; Tarazón E; Barderas MG; Ortega A; Otero M; Molina-Navarro MM; Lago F; González-Juanatey JR; Salvador A; Portolés M; Rivera M
PLoS One; 2014; 9(11):e112971. PubMed ID: 25397948
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress induces different molecular structural alterations in human dilated and ischemic cardiomyopathy.
Ortega A; Roselló-Lletí E; Tarazón E; Molina-Navarro MM; Martínez-Dolz L; González-Juanatey JR; Lago F; Montoro-Mateos JD; Salvador A; Rivera M; Portolés M
PLoS One; 2014; 9(9):e107635. PubMed ID: 25226522
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium.
Moniotte S; Kobzik L; Feron O; Trochu JN; Gauthier C; Balligand JL
Circulation; 2001 Mar; 103(12):1649-55. PubMed ID: 11273992
[TBL] [Abstract][Full Text] [Related]
19. [Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy].
Cortés R; Portolés M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Salvador A; Rivera M
Rev Esp Cardiol; 2007 Dec; 60(12):1319-23. PubMed ID: 18082099
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioactive myocardial transforming growth factor-β in advanced human heart failure.
Khan S; Joyce J; Margulies KB; Tsuda T
Circ J; 2014; 78(11):2711-8. PubMed ID: 25298166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
